Cryoport Lowered FY23 Sales Guidance To $233M-$243M, Down From $270M-$290M Versus Consensus Of $274.85M
Portfolio Pulse from Benzinga Newsdesk
Cryoport has reduced its FY23 sales guidance to $233M-$243M, down from the previous range of $270M-$290M. This is below the consensus estimate of $274.85M.
July 13, 2023 | 8:44 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cryoport's lowered FY23 sales guidance, which is below consensus estimates, may negatively impact its stock price.
Cryoport's revised sales guidance for FY23 is significantly lower than the previous range and also below the consensus estimate. This could lead to a negative sentiment among investors, potentially causing a drop in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100